The race to develop a coronavirus vaccine heated up on global stock markets on Thursday as shares in China’s CanSino Biologics surged on their first day of trading in Shanghai while Germany’s CureVac prepared to sell shares in New York.
開發新型冠狀病毒疫苗的競賽周四在全球股市升溫。中國康希諾生物(CanSino Biologics)股票在上海交易首日飆升，而德國的CureVac準備在紐約發行股票。
您已閱讀7%（318字），剩余93%（4408字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。